Challenges of ethnicity in SLE

Best Practice and Research: Clinical Rheumatology

Volumn 23, Issue 4, 2009, Pages 549-561

  Kumar, Kanta ^a,b   Chambers, Sharon ^c   Gordon, Caroline ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

adherence; beliefs; cultural; patient education; SLE; therapy

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; STEROID;

ALTERNATIVE MEDICINE; COMMUNICATION SKILL; COPING BEHAVIOR; CULTURAL SENSITIVITY; CULTURAL VALUE; DISEASE ACTIVITY; DISEASE PREDISPOSITION; DOCTOR PATIENT RELATION; EDUCATION PROGRAM; ETHNIC DIFFERENCE; GEOGRAPHIC DISTRIBUTION; HEALTH BELIEF; HEALTH CARE ACCESS; HELP SEEKING BEHAVIOR; HUMAN; INCIDENCE; INFECTION; KIDNEY FAILURE; LUPUS ERYTHEMATOSUS NEPHRITIS; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT EDUCATION; PATIENT SATISFACTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RELIGION; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

AFRICAN CONTINENTAL ANCESTRY GROUP; ASIAN CONTINENTAL ANCESTRY GROUP; EUROPE; HUMANS; INCIDENCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MEDICATION ADHERENCE; NORTH AMERICA; PREVALENCE;

EID: 67649814985     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2009.04.005     Document Type: Review

References (68)

1. Johnson A.E., Gordon C., Palmer R.G., and Bacon P.A. The Prevalence and incidence of systemic lupus-erythematosus in Birmingham, England - relationship to ethnicity and Country of Birth. Arthritis Rheum 38 4 (1995) 551-558
2. Hopkinson N.D. Systemic lupus erythematosus: epidemiological clues to aetiology. Br J Hosp Med 45 5 (1991) 291-293
3. McCarty D.J., Manzi S., Medsger Jr. T.A., et al. Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum 38 9 (1995) 1260-1270
4. Uramoto K.M., Michet Jr. C.J., Thumboo J., et al. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum 42 1 (1999) 46-50
5. Maskarinec G., and Katz A.R. Prevalence of systemic lupus erythematosus in Hawaii: is there a difference between ethnic groups?. Hawaii Med J 54 2 (1995) 406-409
6. Hart H.H., Grigor R.R., and Caughey D.E. Ethnic difference in the prevalence of systemic lupus erythematosus. Ann Rheum Dis 42 5 (1983) 529-532
7. Danchenko N., Satia J.A., and Anthony M.S. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 15 5 (2006) 308-318
8. Anstey N.M., Bastian I., Dunckley H., and Currie B.J. Systemic lupus erythematosus in Australian aborigines: high prevalence, morbidity and mortality. Aust N Z J Med 23 6 (1993) 646-651
9. Houghton K.M., Page J., Cabral D.A., et al. Systemic lupus erythematosus in the pediatric North American native population of British Columbia. J Rheumatol 33 1 (2006) 161-163
10. Patel M., Clarke A.M., Bruce I.N., and Symmons D.P. The prevalence and incidence of biopsy-proven lupus nephritis in the UK: evidence of an ethnic gradient. Arthritis Rheum 54 9 (2006) 2963-2969
11. Cooper G.S., Parks C.G., Treadwell E.L., et al. Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States. Lupus 11 3 (2002) 161-167
12. Ward M.M., and Studenski S. Clinical manifestations of systemic lupus erythematosus. Identification of racial and socioeconomic influences. Arch Intern Med 150 4 (1990) 849-853
13. Burling F., Ng J., Thein H., et al. Ethnic, clinical and immunological factors in systemic lupus erythematosus and the development of lupus nephritis: results from a multi-ethnic New Zealand cohort. Lupus 16 10 (2007) 830-837
14. Uribe A.G., and Alarcon G.S. Ethnic disparities in patients with systemic lupus erythematosus. Curr Rheumatol Rep 5 5 (2003) 364-369
15. Samanta A., Feehally J., Roy S., et al. High prevalence of systemic-disease and mortality in Asian subjects with systemic lupus-erythematosus. Ann Rheum Dis 50 7 (1991) 490-492
16. Fernandez M., Alarcon G.S., Calvo-Alen J., et al. A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE. Arthritis Rheum 57 4 (2007) 576-584
17. Bertoli A.M., Vila L.M., Reveille J.D., and Alarcon G.S. Systemic lupus erythaematosus in a multiethnic US cohort (LUMINA) LIII: disease expression and outcome in acute onset lupus. Ann Rheum Dis 67 (2008) 500-504
18. Walsh S.J., Algert C., Gregorio D.I., et al. Divergent racial trends in mortality from systemic lupus erythematosus. J Rheumatol 22 9 (1995) 1663-1668
19. Alarcon G.S., McGwin Jr. G., Bartolucci A.A., et al. Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual. Arthritis Rheum 44 12 (2001) 2797-2806
20. Duran S., Apte M., and Alarcon G.S. Poverty, not ethnicity, accounts for the differential mortality rates among lupus patients of various ethnic groups. J Natl Med Assoc 99 10 (2007) 1196-1198
21. Barr R.G., Seliger S., Appel G.B., et al. Prognosis in proliferative lupus nephritis: the role of socio-economic status and race/ethnicity. Nephrol Dial Transplant 18 10 (2003) 2039-2046
22. Johnson S.R., Urowitz M.B., Ibanez D., and Gladman D.D. Ethnic variation in disease patterns and health outcomes in systemic lupus erythematosus. J Rheumatol 33 10 (2006) 1990-1995
23. Alarcon G.S., McGwin Jr. G., Sanchez M.L., et al. Systemic lupus erythematosus in three ethnic groups. XIV. Poverty, wealth, and their influence on disease activity. Arthritis Rheum 51 1 (2004) 73-77
24. Adler M., Chambers S.C., Edwards C., et al. An assessement of renal failure in an SLE cohort with special reference to ethnicity, over a 25 year period. Rheumatology 45 (2006) 1144-1147
25. Kumar K., Daley E., Carruthers D.M., et al. Delay in Presentation to primary care physicians is the main reason why patients with rheumatoid arthritis are seen late by rheumatologist. Rheumatology 46 9 (2007) 1438-1440
26. Sheppard J., Kumar K., Buckley C.D., et al. 'I just thought it was normal aches and pains; a qualitative study of decision making processes in with early rheumatoid arthritis. Rheumatology 47 10 (2008) 1577-1582
27. Gilley J. Towards rational prescribing. BMJ 308 6931 (1994) 731-732
28. Beardon P.H., McGilchrist M.M., McKendrick A.D., et al. Primary non-compliance with prescribed medication in primary care. BMJ 307 6908 (1993) 846-848
29. Treharne G.J., Lyons A.C., Hale E.D., et al. 'Compliance' is futile but is 'concordance' between rheumatology patients and health professionals attainable?. Rheumatology (Oxford) 45 1 (2006) 1-5
30. Petri M., Perez-Gutthann S., Longenecker J.C., and Hochberg M. Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am J Med 91 4 (1991) 345-353
31. Bruce I.N., Gladman D.D., and Urowitz M.B. Factors associated with refractory renal disease in patients with systemic lupus erythematosus: the role of patient nonadherence. Arthritis Care Res 13 6 (2000) 406-408
32. Rojas-Serrano J., and Cardiel M.H. Lupus patients in an emergency unit. Causes of consultation, hospitalization and outcome. A cohort study. Lupus 9 8 (2000) 601-606
33. Osterberg L., and Terrence B. Adherence to medication. N Engl J Med 353 (2005) 487-497
34. Koehler A.M., and Maibach H.I. Electronic monitoring in medication adherence measurement. Implications for dermatology. Am J Clin Dermatol 2 1 (2001) 7-12
35. Hugen P.W., Langebeek N., Burger D.M., et al. Assessment of adherence to HIV protease inhibitors: comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoring. J Acquir Immune Defic Syndrs 30 3 (2002) 324-334
36. Bangsberg D.R., Hecht F.M., Clague H., et al. Provider assessment of adherence to HIV antiretroviral therapy. J Acquir Immune Defic Syndr 26 5 (2001) 435-442
37. Koneru S., Shishov M., Ware A., et al. Effectively measuring adherence to medications for systemic lupus erythematosus in a clinical setting. Arthritis Rheum 57 6 (2007) 1000-1006
38. de K.E., van der H.D., Landewe R., et al. The compliance-questionnaire-rheumatology compared with electronic medication event monitoring: a validation study. J Rheumatol 30 11 (2003) 2469-2475
39. Garcia-Gonzalez A., Richardson M., Garcia Popa-Lisseanu M., et al. Treatment adherence in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol 27 7 (2008) 883-889
40. McElhone K., Teh L.-S., Walker J., and Abbott J. Treatment adherence in systemic lupus erythematosus (SLE). Rheumatology 44 Suppl. (2005) i141
41. Koneru S., Kocharla L., Higgins G.C., et al. Adherence to medications in systemic lupus erythematosus. J Clin Rheumatol 14 4 (2008) 195-201
42. Garcia Popa-Lisseanu M.G., Greisinger A., Richardson M., et al. Determinants of treatment adherence in ethnically diverse, economically disadvantaged patients with rheumatic disease. J Rheumatol 32 5 (2005) 913-919
43. Morgan M. The significance of ethnicity for health promotion: patients' use of anti-hypertensive drugs in inner London. Int J Epidemiol 24 Suppl. 1 (1995) S79-S84
44. Lip G.Y., Khan H., Bhatnagar A., et al. Ethnic differences in patient perceptions of heart failure and treatment: the West Birmingham heart failure project. Heart 90 9 (2004) 1016-1019
45. Shenolikar R.A., Balkrishnan R., Camacho F.T., et al. Race and medication adherence in medicaid enrollees with type-2 diabetes. J Natl Med Assoc 98 7 (2006) 1071-1077
46. Lawton J., Ahmad N., Hallowell N., et al. Perceptions and experiences of taking oral hypoglycaemic agents among people of Pakistani and Indian origin: qualitative study. BMJ 330 7502 (2005) 1247
47. Helliwell P.S., and Ibranhim G. Ethnic differences in responses to disease modifying drugs. Rheumatology 42 (2003) 1197-1201
48. Connell P., McKevitt C., and Wolfe C. Strategies to manage hypertension: a qualitative study with black Caribbean patients. Br J Gen Pract 55 (2005) 357-361
49. Rathwell T., and Phillips D.R. Health, race & ethnicity (1986), Croon Helm, London
50. Goldberg A.I., Cohen G., and Rubin A.H. Physician assessments of patient compliance with medical treatment. Soc Sci Med 47 11 (1998) 1873-1876
51. Mosley-Williams A., Lumley M.A., Gillis M., et al. Barriers to treatment adherence among African American and white women with systemic lupus erythematosus. Arthritis Rheum 47 6 (2002) 630-638
52. Morisky D.E., Green L.W., and Levine D.M. Concurrent and predictive-validity of a self-reported measure of medication adherence. Med Care 24 1 (1986) 67-74
53. Chambers S.A., Raine R., Rahman A., and Isenberg D. Ethnicity and adherence to medications in patients with systemic lupus erythematosus (SLE). Arthritis Rheum 56 9 Suppl. (2007) S731
54. Chambers SA, Raine R, Rahman A, Isenberg D. Why do patients with systemic lupus erythematosus take or fail to take their prescribed medications? A qualitative study in a UK cohort. Rheumatology (Oxford) 2009;48(3):266--71.
55. Pyne D., and Chaabo K. Adherence to immunosuppressant drugs in patients with connective tissue diseases. Rheumatology (Oxford) 46 12 (2007) 1859
56. Chambers S., Raine R., Rahman A., et al. Factors influencing adherence to medications in a group of patients with systemic erythematosus in Jamaica. Lupus 17 (2008) 761-769
57. Thomas V.N., Saleem T., and Abraham R. Barriers to effective uptake of cancer screening among Black and minority ethnic groups. Int J Palliat Nurs 11 11 (2005) 564-571
58. Kumar K., Gordon C., Toescu V., et al. Beliefs about medicines in patients with RA and SLE: a comparison between patients of South Asian and White British origin. Rheumatology 47 5 (2008) 690-697
59. Phatak H.M., and Thomas J. Relationships between beliefs about medications and nonadherence to prescribed chronic medications. Ann Pharmacother 40 10 (2006) 1737-1742
60. Horne R., and Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 47 6 (1999) 555-567
61. Williams A.M., Lumley M.A., Gillis M., et al. Barriers to treatment adherence among African American and White Women with systemic lupus erythematosus. Arthritis Rheum 47 6 (2002) 630-638
62. Moore, Petri M.A., Manzi S., et al. The use of alternative medical therapies in patients with systemic lupus erythematosus. Arthritis Rheum 43 6 (2000) 1410-1418
63. Leong K.P., Pong L.Y., and Chan S.P. Why lupus patients use alternative medicine. Lupus 12 (2003) 659-664
64. Kuo G.M., Hawley S.T., Weiss L.T., et al. Factors associated with herbal use among urban multiethnic primary care patients: a cross-sectional survey. Complement Altern Med 4 18 (2004)
65. Sutcliffe N., Clarke A.E., Gordon C., et al. The association of socio-economic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus. Rheumatology 38 (1999) 1130-1137
66. Lip G.Y., Kamath S., Jafri M., et al. Ethnic differences in patient perceptions of atrial fibrillation and anticoagulation therapy: the West Birmingham Atrial Fibrillation Project. Stroke 33 1 (2002) 238-242
67. Kumar K., Deeming A., Gordon C., et al. Experience with a Punjabi, Urdu and Hindi rheumatology telephone helpline. Musculoskeletal Care 7 3 (2009)
68. Bertoli A., and Alarcon G. Epidemiology of systemic lupus erythematosus. In: Tsokos G., Gordon C., and Smolen J. (Eds). Systemic lupus erythematosus: a companion to rheumatology. 1st edn. (2007), Mosby Elsevier, Philadelphia 1-18